ovarian hyperstimulation syndrome
Information
- Disease name
- ovarian hyperstimulation syndrome
- Disease ID
- DOID:5425
- Description
- "An ovarian disease that is characterized by cystic enlargement of the ovaries and a fluid shift from the intravascular to the third space and has_symptom abdominal pain, has_symptom nausea and has_symptom vomiting. This disease is an iatrogenic complication of assisted reproduction technology." [url:https\://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205536/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05638529 | Active, not recruiting | Phase 4 | Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome | May 1, 2019 | December 31, 2023 |
| NCT02670304 | Completed | Phase 4 | Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS | January 2012 | August 2013 |
| NCT00349258 | Completed | Phase 4 | The Use of GnRH Agonist Trigger in the Prevention of OHSS | August 2004 | May 2006 |
| NCT02200952 | Completed | Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS | June 30, 2013 | June 30, 2014 | |
| NCT06333691 | Completed | N/A | Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin | October 1, 2022 | February 15, 2024 |
| NCT00329693 | Completed | Phase 2 | Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide | June 2006 | May 2008 |
| NCT00440258 | Completed | Phase 3 | Cabergoline Reduces OHSS | April 2004 | July 2006 |
| NCT00480337 | Completed | N/A | In Vitro Maturation of Immature Oocytes | ||
| NCT00665041 | Completed | Phase 2 | Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome | May 2008 | October 2008 |
| NCT00756028 | Completed | Phase 4 | Short Versus Long Protocol for IVF and IVF+ICSI | January 2009 | December 2015 |
| NCT03876145 | Completed | N/A | The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome | November 12, 2016 | November 20, 2020 |
| NCT03996434 | Completed | Phase 4 | Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS | July 1, 2019 | November 20, 2019 |
| NCT04351126 | Completed | Phase 2 | Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response | April 1, 2019 | February 29, 2020 |
| NCT00835523 | Completed | Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist | May 2008 | July 2010 | |
| NCT00867659 | Completed | N/A | The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors | March 2009 | October 2011 |
| NCT05362734 | Completed | Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger | January 1, 2012 | December 31, 2020 | |
| NCT01009567 | Completed | Phase 1/Phase 2 | Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program | June 2009 | July 2013 |
| NCT01014104 | Completed | Phase 1/Phase 2 | Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome | October 2009 | December 2010 |
| NCT01268761 | Completed | Phase 3 | GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome | April 2012 | July 2013 |
| NCT01427335 | Completed | Phase 3 | Calcium for Prevention of Ovarian Hyperstimulation Syndrome | October 2011 | September 2013 |
| NCT01477970 | Completed | Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS | February 2009 | February 2010 | |
| NCT01500863 | Completed | Phase 4 | Endometrial Receptivity After GnRH Agonist Triggering | November 2011 | |
| NCT01535859 | Completed | Phase 3 | Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers | April 2012 | June 2016 |
| NCT01569256 | Completed | N/A | Ovarian Hyperstimulation Syndrome and Cabergoline | March 2008 | March 2009 |
| NCT01815138 | Completed | Phase 4 | Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS | March 2013 | October 2016 |
| NCT05588635 | Completed | Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy | November 1, 2019 | March 1, 2021 | |
| NCT02686151 | Not yet recruiting | Phase 3 | The Letrozole Administration During Luteal Phase | December 2023 | December 2024 |
| NCT03794037 | Suspended | Phase 2 | Montelukast for Prevention & Treatment of OHSS | December 5, 2018 | December 2023 |
| NCT02701452 | Terminated | N/A | Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response | February 26, 2016 | January 1, 2019 |
| NCT01606709 | Terminated | Phase 4 | Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation | April 2012 | December 2014 |
| NCT01714648 | Terminated | Phase 4 | Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? | November 2012 | January 2014 |
| NCT02610608 | Terminated | Medical Assistance for the Procreation and Risk of Thrombosis. | February 2, 2016 | November 20, 2016 | |
| NCT04797338 | Unknown status | Phase 4 | Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders | December 29, 2017 | September 30, 2021 |
| NCT00417144 | Unknown status | Phase 4 | Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients | November 2003 | May 2007 |
| NCT02084940 | Unknown status | Long Acting GnRH Antagonist in PCOS Women Undergoing IVF | March 2014 | February 2015 | |
| NCT02202278 | Unknown status | Study of Serum Levels of Oxidative Stress Markers in Ovarian Hyperstimulation Patients | June 2014 | October 2014 | |
| NCT02329483 | Unknown status | Monitoring the Early Follicular Phase With Androstenedione in Low-dose Step-up Ovulation Induction in High Responders | December 2014 | June 2015 | |
| NCT02392520 | Unknown status | N/A | Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) | May 2015 | December 2016 |
| NCT02620605 | Unknown status | Phase 3 | The Influence of Timing of Cabergoline Initiation on Prevention of OHSS | December 20, 2017 | April 2019 |
| NCT02846493 | Unknown status | Phase 2 | Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome | August 2016 | June 2018 |
| NCT03071172 | Unknown status | Phase 3 | Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET | March 2017 | May 2018 |
| NCT03188471 | Unknown status | Phase 4 | Preventive Application of GnRH Antagonist on Early OHSS | January 2017 | March 2018 |
| NCT00119925 | Unknown status | N/A | 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists" | October 2005 | May 2009 |
| NCT05198128 | Unknown status | N/A | Ovarian Hyperstimulation Syndrome Using Calcium Infusion | March 1, 2022 | May 10, 2023 |
| NCT01979341 | Withdrawn | N/A | The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes | October 2013 | September 2016 |
| NCT00617864 | Withdrawn | N/A | The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome | September 2007 | |
| NCT00365027 | Withdrawn | N/A | Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation. |
- Disase is a (Disease Ontology)
- DOID:1100
- Cross Reference ID (Disease Ontology)
- MESH:D016471
- Cross Reference ID (Disease Ontology)
- MIM:608115
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:129635004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0085083
- Exact Synonym (Disease Ontology)
- secondary Meig's syndrome
- MedGen concept unique identifier (MedGen Concept name)
- C0085083
- MedGen unique identifier (MedGen Concept name)
- 38966
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016471